文献速递淋巴瘤

ZAP-70增强IGHV未突变慢性淋巴细胞白血病中的强直性B细胞受体与CCR7信号

ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.
PubMed 文献 · Blood Adv · 2024-01-01

研究探讨ZAP-70在IGHV未突变慢性淋巴细胞白血病(CLL)中增强强直性B细胞受体(BCR)信号和CCR7信号的作用。研究发现该强直性BCR信号仅见于IGHV未突变CLL,依赖ZAP-70介导的AKT及GSK-3β激活,并通过磷酸化LCP1丝氨酸-5调控CCL19/CCL21诱导的趋化。

要点

  • 强直性BCR信号仅存在于IGHV未突变CLL,且依赖ZAP-70。
  • ZAP-70通过AKT/GSK-3β轴增强强直性BCR信号。
  • ZAP-70通过磷酸化LCP1丝氨酸-5调控CCR7介导的趋化。

核心结论

  • ZAP-70汇聚了仅见于IGHV未突变CLL的强直性BCR信号与CCR7介导的趋化。

研究设计与样本

  • 研究类型为体外细胞与分子生物学研究,样本未在原文摘要中报告。

主要发现

  • 强直性BCR信号仅见于IGHV未突变CLL,依赖ZAP-70介导的AKT及其下游靶点GSK-3β的激活。
  • 该信号伴随CD19和SRC稳态激活增加,且不见于不一致表达ZAP-70的IGHV突变CLL细胞。
  • ZAP-70通过磷酸化LCP1丝氨酸-5调控CLL细胞迁移。
  • CCL19和CCL21诱导的趋化受ZAP-70表达调控并依赖其增强CCR7至LCP1的信号传导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Expression of ZAP-70 in a subset of patients with chronic lymphocytic leukemia (CLL) positively correlates with the absence of immunoglobulin heavy-chain gene (IGHV) mutations and is indicative of a more active disease and shorter treatment-free survival. We recently demonstrated that ZAP-70 regulates the constitutive expression of CCL3 and CCL4, activation of AKT, and expression of MYC in the absence of an overt B-cell receptor (BCR) signal, bona fide functions of BCR activation. We, here, provide evidence that these features relate to the presence of a constitutive tonic BCR signal, exclusively found in IGHV-unmutated CLL and dependent on the ZAP-70-mediated activation of AKT and its downstream target GSK-3β. These findings are associated with increased steady-state activation of CD19 and SRC. Notably this tonic BCR signal is not present in IGHV-mutated CLL cells, discordantly expressing ZAP-70. Results of quantitative mass spectrometry and phosphoprotein analyses indicate that this ZAP-70-dependent, tonic BCR signal regulates CLL cell migration through phosphorylation of LCP1 on serine-5. Indeed, we show that CCL19- and CCL21-induced chemotaxis is regulated by and dependent on the expression of ZAP-70 through its function to enhance CCR7 signaling to LCP1. Thus, our data demonstrate that ZAP-70 converges a tonic BCR signal, exclusively present in IGHV-unmutated CLL and CCR7-mediated chemotaxis.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Chen J, Sathiaseelan V, Reddy Chilamakuri CS, et al. ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia. Blood Adv. 2024. PMID: 38113463. doi:10.1182/bloodadvances.2022009557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。